{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:32:23Z","timestamp":1759941143695,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Astellas Pharma Europe (BE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40292-016-0177-9","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T20:21:57Z","timestamp":1483647717000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study"],"prefix":"10.1007","volume":"24","author":[{"given":"Robert","family":"Lins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-7033","authenticated-orcid":false,"given":"Yves","family":"Haerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"issue":"7","key":"177_CR1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281\u2013357.","journal-title":"J Hypertens."},{"unstructured":"Statistiques Sanitaires Mondiales 2012. http:\/\/www.who.int\/gho\/publications\/world_health_statistics\/2012\/fr\/ . Accessed 26 July 2016.","key":"177_CR2"},{"issue":"7653","key":"177_CR3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336(7653):1121\u20133.","journal-title":"BMJ"},{"issue":"3 Pt 2","key":"177_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-8703(99)70312-1","volume":"138","author":"J He","year":"1999","unstructured":"He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999;138(3 Pt 2):211\u20139.","journal-title":"Am Heart J."},{"issue":"11","key":"177_CR5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1586\/14779072.2013.843451","volume":"11","author":"A Zanchetti","year":"2013","unstructured":"Zanchetti A. Antihypertensive therapy: from 2003 to 2013 and beyond. Expert Rev Cardiovasc Ther. 2013;11(11):1443\u20136.","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"177_CR6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/HJH.0b013e32834550d0","volume":"29","author":"G Mancia","year":"2011","unstructured":"Mancia G, Parodi A, Merlino L, Corrao G. Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class. J Hypertens. 2011;29:1012\u20138.","journal-title":"J Hypertens."},{"key":"177_CR7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/080370598438564","volume":"7","author":"LM Ruilope","year":"1998","unstructured":"Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press Suppl. 1998;7:22\u20136.","journal-title":"Blood Press Suppl."},{"issue":"1","key":"177_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2005.04140.x","volume":"8","author":"DA Sicca","year":"2006","unstructured":"Sicca DA. Pharmacotherapy review: calcium channel blockers. J Clin Hypertens (Greenwich). 2006;8(1):53\u20136.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"Suppl A","key":"177_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/eurheartj\/18.suppl_A.71","volume":"18","author":"LH Opie","year":"1997","unstructured":"Opie LH. Pharmacological differences between calcium antagonists. Eur Heart J. 1997;18(Suppl A):71\u20139.","journal-title":"Eur Heart J"},{"key":"177_CR10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2012.33","volume":"9","author":"L Paulis","year":"2012","unstructured":"Paulis L, Steckelings UM, Unger T. Key advances in antihypertensive treatment. Nat Rev Cardiol. 2012;9:276\u201385.","journal-title":"Nat Rev Cardiol."},{"issue":"9 Pt 1","key":"177_CR11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0895-7061(01)02167-7","volume":"14","author":"MR Weir","year":"2001","unstructured":"Weir MR, Rosenberger C, Fink JC. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens. 2001;14(9 Pt 1):963\u20138.","journal-title":"Am J Hypertens."},{"key":"177_CR12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/147323000203000317","volume":"30","author":"CS Liau","year":"2002","unstructured":"Liau CS, Chien KL, Chao CL, Lee TM. Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients. J Int Med Res. 2002;30:330\u20136.","journal-title":"J Int Med Res."},{"issue":"4","key":"177_CR13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12325-013-0018-3","volume":"30","author":"A Hagendorff","year":"2013","unstructured":"Hagendorff A, Freytag S, M\u00fcller A, Klebs S. Pill burden in hypertensive patients treated with single-pill combination therapy\u2014an observational study. Adv Ther. 2013;30(4):406\u20139.","journal-title":"Adv Ther."},{"key":"177_CR14","first-page":"2","volume":"114","author":"C Korstanje","year":"2000","unstructured":"Korstanje C. Barnidipine, a long-acting slow onset calcium antagonist. Int J Clin Pract Suppl. 2000;114:2\u20135.","journal-title":"Int J Clin Pract Suppl."},{"issue":"7","key":"177_CR15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003495-200161070-00007","volume":"61","author":"HS Malhotra","year":"2001","unstructured":"Malhotra HS, Plosker GL. Barnidipine. Drugs. 2001;61(7):989\u201396.","journal-title":"Drugs."},{"key":"177_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/080370598438999","volume":"2","author":"PA Zwieten Van","year":"1998","unstructured":"Van Zwieten PA. The pharmacological properties of lipophilic calcium antagonists. Blood Press Suppl. 1998;2:5\u20139.","journal-title":"Blood Press Suppl."},{"key":"177_CR17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/080370598438546","volume":"7","author":"L Argenziano","year":"1998","unstructured":"Argenziano L, Izzo R, Iovino G, et al. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients. Blood Press Suppl. 1998;7:9\u201314.","journal-title":"Blood Press Suppl."},{"key":"177_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/080370598438555","volume":"1","author":"C Spieker","year":"1998","unstructured":"Spieker C. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension. Blood Press Suppl. 1998;1:15\u201321.","journal-title":"Blood Press Suppl."},{"issue":"3","key":"177_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.curtheres.2008.06.002","volume":"69","author":"G Rossetti","year":"2008","unstructured":"Rossetti G, Pizzocri S, Brasca F, et al. Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study. Curr Ther Res Clin Exp. 2008;69(3):192\u2013206.","journal-title":"Curr Ther Res Clin Exp."},{"key":"177_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/147323000603400410","volume":"34","author":"W Zhu","year":"2006","unstructured":"Zhu W, Li T, Ni C, et al. Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension. J Int Med Res. 2006;34:406\u201312.","journal-title":"J Int Med Res."},{"key":"177_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/080370598438573","volume":"1","author":"JW Velden Van der","year":"1998","unstructured":"Van der Velden JW, Beudeker HJ, Nishi M. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine. Blood Press Suppl. 1998;1:27\u20139.","journal-title":"Blood Press Suppl."},{"issue":"10","key":"177_CR22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0011-393X(99)80059-9","volume":"60","author":"LA Giorgio De","year":"1999","unstructured":"De Giorgio LA, Orlandini F, Malasoma P, Zappa A. Double-blind, crossover study of lercanidipine versus amlodipine in the treatment of mild-to-moderate essential hypertension. Curr Ther Res. 1999;60(10):511\u201320.","journal-title":"Curr Ther Res."},{"issue":"3","key":"177_CR23","first-page":"173","volume":"1","author":"C Borghi","year":"2005","unstructured":"Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag. 2005;1(3):173\u201382.","journal-title":"Vasc Health Risk Manag."},{"issue":"4","key":"177_CR24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1179\/2295333715Y.0000000012","volume":"70","author":"R Lins","year":"2015","unstructured":"Lins R, Marckx P, Vandebeek R, Vanhoutvinck C, Neuville O. Barnidipine real-life tolerability in arterial hypertension: results from the BASIC-HT study. Acta Clin Belg. 2015;70(4):244\u201350.","journal-title":"Acta Clin Belg."},{"issue":"2","key":"177_CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14779072.3.2.207","volume":"3","author":"CS Liau","year":"2005","unstructured":"Liau CS. Barnidipine: a new calcium channel blocker for hypertension treatment. Expert Rev Cardiovasc Ther. 2005;3(2):207\u201313.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"6","key":"177_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11886-002-0110-9","volume":"4","author":"FH Messerli","year":"2002","unstructured":"Messerli FH. Vasodilatory edema: a common side effect of antihypertensive therapy. Curr Cardiol Rep. 2002;4(6):479\u201382.","journal-title":"Curr Cardiol Rep."},{"issue":"11","key":"177_CR27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0895-7061(02)03000-5","volume":"15","author":"G Leonetti","year":"2002","unstructured":"Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens. 2002;15(11):932\u201340.","journal-title":"Am J Hypertens."},{"issue":"5","key":"177_CR28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s002100100468","volume":"364","author":"BJ Janssen","year":"2001","unstructured":"Janssen BJ, Kam KL, Smits JF. Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(5):414\u201321.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"6","key":"177_CR29","first-page":"495","volume":"17","author":"KA Jamerson","year":"2004","unstructured":"Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Initial angiotensin-converting enzyme inhibitor\/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Med. 2004;17(6):495\u2013501.","journal-title":"Am J Med."},{"issue":"2","key":"177_CR30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2010.08.007","volume":"124","author":"H Makani","year":"2011","unstructured":"Makani H, Bangalore S, Romero J, Wever-Pinzon O, Messerli FH. Effect of renin\u2013angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med. 2011;124(2):128\u201335.","journal-title":"Am J Med."},{"issue":"3","key":"177_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.jhh.1002140","volume":"21","author":"R Fogari","year":"2007","unstructured":"Fogari R, Zoppi A, Derosa G, Mugellini A, Lazzari P, Rinaldi A, Fogari E, Preti P. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens. 2007;21(3):220\u20134.","journal-title":"J Hum Hypertens."},{"issue":"4","key":"177_CR32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"T Philipp","year":"2007","unstructured":"Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Clin Ther. 2007;29(4):563\u201380.","journal-title":"Clin Ther."},{"key":"177_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/VHRM.S9989","volume":"6","author":"R D\u00fcsing","year":"2010","unstructured":"D\u00fcsing R. Optimizing blood pressure control through the use of fixed combinations. Vasc Health Risk Manag. 2010;6:321\u20135.","journal-title":"Vasc Health Risk Manag."},{"issue":"9489","key":"177_CR34","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Mehlsen J. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895\u2013906.","journal-title":"Lancet"},{"issue":"23","key":"177_CR35","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, Velazquez EJ. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417\u201328.","journal-title":"N Engl J Med."},{"doi-asserted-by":"publisher","unstructured":"Chi C, Tai C, Bai B, Yu S, Karamanou M, Wang J, Xu Y. Angiotensin system blockade combined with calcium channel blockers is superior to other combinations in cardiovascular protection with similar blood pressure reduction: a meta-analysis in 20,451 hypertensive patients. J Clin Hypertens (Greenwich). 2016. doi: 10.1111\/jch.12771 . (Epub ahead of print).","key":"177_CR36","DOI":"10.1111\/jch.12771"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-016-0177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-016-0177-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-016-0177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T02:17:59Z","timestamp":1568686679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-016-0177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1007\/s40292-016-0177-9","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"type":"print","value":"1120-9879"},{"type":"electronic","value":"1179-1985"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}